7.08
0.84%
-0.06
Dopo l'orario di chiusura:
7.00
-0.08
-1.13%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché AUPH Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$7.14
Aprire:
$7.17
Volume 24 ore:
919.89K
Relative Volume:
0.66
Capitalizzazione di mercato:
$1.01B
Reddito:
$175.51M
Utile/perdita netta:
$-78.02M
Rapporto P/E:
-13.36
EPS:
-0.53
Flusso di cassa netto:
$-34.18M
1 W Prestazione:
+8.42%
1M Prestazione:
+13.10%
6M Prestazione:
+39.10%
1 anno Prestazione:
-15.71%
Aurinia Pharmaceuticals Inc Stock (AUPH) Company Profile
Nome
Aurinia Pharmaceuticals Inc
Settore
Industria
Telefono
250-744-2487
Indirizzo
#140, 14315 - 118 AVENUE, EDMONTON, BC
Aurinia Pharmaceuticals Inc Stock (AUPH) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2022-11-04 | Downgrade | Oppenheimer | Outperform → Perform |
2022-05-05 | Ripresa | Cantor Fitzgerald | Overweight |
2021-12-10 | Aggiornamento | Oppenheimer | Perform → Outperform |
2021-10-28 | Downgrade | Oppenheimer | Outperform → Perform |
2021-01-25 | Reiterato | H.C. Wainwright | Buy |
2020-11-03 | Reiterato | H.C. Wainwright | Buy |
2020-06-17 | Iniziato | BTIG Research | Buy |
2020-05-05 | Iniziato | Cowen | Outperform |
2020-01-10 | Iniziato | Jefferies | Buy |
2019-12-16 | Reiterato | H.C. Wainwright | Buy |
2018-03-16 | Reiterato | Cantor Fitzgerald | Overweight |
2018-02-08 | Iniziato | RBC Capital Mkts | Outperform |
2017-10-30 | Reiterato | H.C. Wainwright | Buy |
2017-05-18 | Reiterato | H.C. Wainwright | Buy |
2017-04-11 | Iniziato | Cantor Fitzgerald | Overweight |
2017-03-22 | Reiterato | FBR & Co. | Outperform |
2016-12-30 | Reiterato | H.C. Wainwright | Buy |
2016-08-17 | Reiterato | H.C. Wainwright | Buy |
2016-06-30 | Iniziato | H.C. Wainwright | Buy |
2015-05-08 | Iniziato | MLV & Co | Buy |
Mostra tutto
Aurinia Pharmaceuticals Inc Borsa (AUPH) Ultime notizie
Aurinia Pharmaceuticals: This Recovery Can Continue (AUPH) - Seeking Alpha
Aurinia Pharmaceuticals (NASDAQ:AUPH) Rating Reiterated by Cantor Fitzgerald - Defense World
Aurinia Pharmaceuticals (NASDAQ:AUPH) Trading 4% Higher - MarketBeat
Aurinia Pharmaceuticals (NASDAQ:AUPH) Earns "Overweight" Rating from Cantor Fitzgerald - MarketBeat
Bank of New York Mellon Corp Has $2.79 Million Stock Holdings in Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) - MarketBeat
PFG Investments LLC Raises Position in Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) - Defense World
Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Shares Sold by Jupiter Asset Management Ltd. - MarketBeat
Aurinia Pharmaceuticals (NASDAQ:AUPH) Shares Gap Up to $6.58 - MarketBeat
How the (AUPH) price action is used to our Advantage - Stock Traders Daily
Aurinia Pharmaceuticals reshuffles board, adds new director By Investing.com - Investing.com Australia
Aurinia to Participate in 2024 Cantor Fitzgerald Global Healthcare Conference - Business Wire
Aurinia Pharmaceuticals (AUPH) Stock Gains After Hours Following Board Realignment - Stocks Telegraph
Aurinia Pharmaceuticals reshuffles board, adds new director - Investing.com
Aurinia Pharmaceuticals Announces Board Restructuring and Director Changes - TipRanks
Aurinia Pharmaceuticals reshuffles board, adds new director - Investing.com India
Aurinia Pharmaceuticals reshuffles board, adds new director By Investing.com - Investing.com UK
Aurinia Announces Board Restructuring - Business Wire
Aurinia Pharmaceuticals (NASDAQ:AUPH) Given “Overweight” Rating at Cantor Fitzgerald - Defense World
Aurinia Pharmaceuticals (NASDAQ:AUPH) Shares Down 3.2% - MarketBeat
Aurinia Pharmaceuticals (NASDAQ:AUPH) Shares Up 3.3% - Defense World
Aurinia Pharmaceuticals (NASDAQ:AUPH) Stock Price Up 3.3% - MarketBeat
HC Wainwright Reaffirms "Buy" Rating for Aurinia Pharmaceuticals (NASDAQ:AUPH) - MarketBeat
H.C. Wainwright reiterates Buy rating on Aurinia Pharma shares - Investing.com
Aurinia doses first subject in Phase Ia trial of AUR200 for autoimmune diseases - Clinical Trials Arena
Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Surges 30% Yet Its Low P/S Is No Reason For Excitement - Simply Wall St
Traders Purchase High Volume of Aurinia Pharmaceuticals Call Options (NASDAQ:AUPH) - MarketBeat
Aurinia Announces First Participant Dosed in AUR200 Single Ascending Dose Trial - sharewise
Aurinia Announces First Participant Dosed in AUR200 Single Ascending Dose Trial - Business Wire
Aurinia to Participate in H.C. Wainwright 26th Annual Global Investment Conference - Manchestertimes
Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Short Interest Down 13.8% in August - MarketBeat
Aurinia to Participate in H.C. Wainwright 26th Annual Global Investment Conference - sharewise
Aurinia Pharmaceuticals (NASDAQ:AUPH) Stock Price Up 2.4% - MarketBeat
Aurinia to Participate in H.C. Wainwright 26th Annual Global Investment Conference - Marketscreener.com
Aurinia to Participate in H.C. Wainwright 26th Annual Global Investment Conference - Business Wire
Aurinia Pharmaceuticals (NASDAQ:AUPH) Stock Price Passes Above 50-Day Moving Average of $5.73 - MarketBeat
Do Options Traders Know Something About Aurinia (AUPH) Stock We Don't? - MSN
Do Options Traders Know Something About Aurinia (AUPH) Stock We Don't? - Yahoo Finance
Aurinia Pharmaceuticals Sees Unusually High Options Volume (NASDAQ:AUPH) - MarketBeat
Aurinia Pharmaceuticals (NASDAQ:AUPH) Stock Price Up 5.4% - Defense World
(AUPH) Technical Pivots with Risk Controls - Stock Traders Daily
Price T Rowe Associates Inc. MD Increases Stock Holdings in Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) - Defense World
Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Short Interest Up 13.1% in July - MarketBeat
Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Stock Position Raised by Vanguard Group Inc. - Defense World
Aurinia Pharmaceuticals (NASDAQ:AUPH) Shares Up 5.4% - MarketBeat
Cetera Advisors LLC Has $301,000 Stock Holdings in Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) - Defense World
California State Teachers Retirement System Trims Holdings in Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) - Defense World
Aurinia Pharmaceuticals faces boardroom shakeup demand By Investing.com - Investing.com Australia
Aurinia Pharmaceuticals faces boardroom shakeup demand - Investing.com
This Insider Has Just Sold Shares In Aurinia Pharmaceuticals - Simply Wall St
AUPHAurinia Pharmaceuticals Inc. Latest Stock News & Market Updates - StockTitan
The growth track for Aurinia Pharmaceuticals Inc (AUPH) has changed recently - SETE News
Aurinia Pharmaceuticals Inc Azioni (AUPH) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Capitalizzazione:
|
Volume (24 ore):